D-0870-2026 Class II Ongoing
FDA drug recall D-0870-2026 was initiated by Insight Pharmaceuticals LLC, A Prestige Consumer Healthcare Company on Sep 15, 2026 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is ongoing. Affected quantity: 2,356,248 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- Sep 30, 2026
- Initiation Date
- Sep 15, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2,356,248 bottles
Product Description
Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) , 0.5 fl oz (15mL) per dropper bottle, STERILE, Dist. by Medtech Products Inc., Tarrytown, NY 10591. NDC: 67172-797-15
Reason for Recall
Lack of Assurance of Sterility
Distribution Pattern
Nationwide in the USA.
Code Information
Lot #: RL25G02, RL25G03, RL25G04, Exp. Date Jul-27; RL25H02, RL25H03, RL25H04, Exp. Date Aug-27; RL25K01, RL25K02, RL25K03, RL25K04, Exp. Date Sep-27; RL25M01, RL25M02, RL25M03, RL25M04, Exp. Date Oct-27; RL25N01, RL25N02, RL25N04, Exp. Date Nov-27.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0870-2026
- openFDA file date
- Oct 23, 2026
- Loaded by RegDataLab
- Oct 24, 2026